Randomized double-blind study of the effect of dexamethasone and methylprednisolone pulse in the control of rheumatoid arthritis flare-up: A preliminary study

International Journal of Rheumatic Diseases

Volumn 17, Issue 4, 2014, Pages 389-393

  Sadra, Vahideh ^a   Khabbazi, Alireza ^a   Kolahi, Susan ^a   Hajialiloo, Mehrzad ^a   Ghojazadeh, Morteza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dexamethasone; Methylprednisolone; Pulse therapy; Rheumatoid arthritis

Indexed keywords

DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISOLONE; ANTIRHEUMATIC AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FLUSHING; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IRAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; ARTHRITIS, RHEUMATOID; COMPARATIVE STUDY; DISEASE COURSE; DRUG PULSE THERAPY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DEXAMETHASONE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HOSPITALS, UNIVERSITY; HUMANS; IRAN; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901254349     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12278     Document Type: Article

References (20)

1. Davatchi F, Jamshidi AR, Banihashemi AT et al. (2008) WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 35, 1384-90.
2. Feduska NJ, Turcotte JG, Gikas PW, Bacon GE, Penner JA (1972) Reversal of renal allograft rejection with intravenous methylprednisolone pulse therapy. J Surg Res 12, 208-15.
3. Sinha A, Bagga A (2008) Pulse steroid therapy. Indian J Pediatr 10, 1057-66.
4. Pasricha JA, Khaitan BK, Raman RS, Chandra M (1995) Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 34, 875-82.
5. Sharada B, Kumar A, Kakker R et al. (1994) Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo controlled study. Rheumatol Int 14, 91-4.
6. Sethi HS, Menon V, Sharma P, Khokhar S, Tandon R (2006) Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Indian J Ophthalmol 54, 177-83.
7. Stasi R, Brunetti M, Pagano A, Stipa E, Masi M, Amadon S (2000) Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Blood Cells Mol Dis 26, 582-6.
8. Pasricha JS, Gupta R (1982) Pulse therapy with dexamethasone in Reiter's disease. Indian J Dermatol Venereol Leprol 48, 358-61.
9. Sood A, Midha V, Sood N, Awasthi G (2002) A prospective, open-label trial assessing dexamethasone pulse therapy in moderate to severe ulcerative colitis. Clin Gastroenterol 35, 328-31.
10. Andersen JC (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 330, 1560-4.
11. van de Vlekkert J, Hoogendijk JE, de Haan RJ et al. (2010) Dexa Myositis Trial. Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord 20, 382-9.
12. Viswanath V, Sonavane AD, Doshi AC, Parab MG (2010) Dexamethasone-cyclophosphamide pulse therapy in progressive systemic sclerosis. Indian J Dermatol 55, 304-5.
13. Kroot EJ, Huisman AM, Van Zeben J, Wouters JM, Van Paassen HC (2006) Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study. Ann NY Acad Sci 1069, 300-6.
14. Hari P, Bagga A, Mantan M (2004) Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr 41, 993-1000.
15. Lashina N, Solov'ev SK, Balabanova RM (2000) Treatment with megadose of dexaven (dexamethasone) versus methylpred6- (methyl-prednisolone) of patients with rheumatoid arthritis. Ter Arkh 72, 28-31.
16. Menon V, Mehrotra A, Saxena R, Jaffery NF (2007) Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Indian J Ophthalmol 55, 355-9.
17. Mantia L, Eoli M, Milanese C, Salmaggi A, Dufour A, Torri V (1994) Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur Neurol 34, 199-203.
18. Ding X, Mao B, Ju Y, Liu Y (2003) Clinical control trial of methylprednisolone and dexamethasone in treatment of intracranial tumor edema. Sichuan Da Xue Xue Bao Yi Xue Ban 34, 327-9.
19. Tandon R, Verma K, Chawla B et al. (2009) Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection. Eye 23, 635-9.
20. Aletaha D, Neogi T, Silman AJ et al. (2010) Rheumatoid arthritis classification criteria. Arthritis Rheum 62, 2569-81.